Neurodegenerative Disorder-Targeting Compound 1

CAT:

804-HY-U00362

Size:

Inquire

Price:

Ask

For price, please contact [email protected]

CAS Number: 1254698-39-9
UNSPSC Description: Neurodegenerative Disorder-Targeting Compound 1 is a calpain inhibitor extracted from patent WO2010128102A1, compound example 63[1].
Target Antigen: Proteasome
Type: Reference compound
Related Pathways: Metabolic Enzyme/Protease
Applications: Neuroscience-Neuromodulation
Field of Research: Neurological Disease
Assay Protocol: https://www.medchemexpress.com/Neurodegenerative-Disorder-Targeting-Compound-1.html
Solubility: 10 mM in DMSO
Smiles: O=C([C@@H](CC1)N(CC2=CC=CC=C2)C1=O)NC(CC3=CC=CC=C3)C(C(NCC4=NC=CC=C4)=O)=O
Molecular Weight: 484.55
References & Citations: [1]Helmut Mack, et al. Carboxamide compounds and their use as calpain inhibitors. WO2010128102A1.
Shipping Conditions: Room temperature
Clinical Information: No Development Reported

Cat	Name
HY-U00362	Neurodegenerative Disorder-Targeting Compound 1
HY-U00362A	(Rac)-Neurodegenerative Disorder-Targeting Compound 1
HY-U00385	Neuromuscular Disorder-Targeting Compound 1
HY-U00361	Itch-Targeting Compound 1
HY-U00310	Neuromuscular-targeting compound 1
HY-U00300	Cancer-Targeting Compound 1
HY-U00393	Arrhythmic-Targeting Compound 1
HY-101750	Arrhythmias-Targeting Compound 1
HY-U00357	Urinary Incontinence-Targeting Compound 1
HY-P10055	PSMA targeting peptide

Cat	Name
T13486-1g	Neurodegenerative Disorder-Targeting Compound 1
T13486-5mg	Neurodegenerative Disorder-Targeting Compound 1
T13486-1mg	Neurodegenerative Disorder-Targeting Compound 1
T13486-10mg	Neurodegenerative Disorder-Targeting Compound 1
T13486-50mg	Neurodegenerative Disorder-Targeting Compound 1
T10059-1mg	Neuromuscular Disorder-Targeting Compound 1
T10059-10mg	Neuromuscular Disorder-Targeting Compound 1
T10059-1g	Neuromuscular Disorder-Targeting Compound 1
T10059-5mg	Neuromuscular Disorder-Targeting Compound 1
T10059-50mg	Neuromuscular Disorder-Targeting Compound 1